Femtobiomed, Inc. engages in the development of pharmaceutical products. Its services include intracellular delivery for cell therapy. The company was founded on July 8, 2011 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company